Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy.
AffiliationInstitute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractRadiotherapy is an essential component of treatment for more than half of newly diagnosed cancer patients. The response to radiotherapy varies widely between individuals and although advances in technology have allowed the adaptation of radiotherapy fields to tumour anatomy, it is still not possible to tailor radiotherapy based on tumour biology. A biomarker of intrinsic radiosensitivity would be extremely valuable for individual dosing, aiding decision making between radical treatment options and avoiding toxicity of neoadjuvant or adjuvant radiotherapy in those unlikely to benefit. This systematic review summarises the current evidence for biomarkers under investigation as predictors of radiotherapy benefit. Only 10 biomarkers were identified as having been evaluated for their radiotherapy-specific predictive value in over 100 patients in a clinical setting, highlighting that despite a rich literature there were few high-quality studies for inclusion. The most extensively studied radiotherapy predictive biomarkers were the radiosensitivity index and MRE11; however, neither has been evaluated in a randomised controlled trial. Although these biomarkers show promise, there is not enough evidence to justify their use in routine practice. Further validation is needed before biomarkers can fulfil their potential and predict treatment outcomes for large numbers of patients.
CitationBiomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy. 2015: Clin Oncol
- Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.
- Authors: Tanić M, Krivokuća A, Čavić M, Mladenović J, Plesinac Karapandžić V, Beck S, Radulović S, Susnjar S, Janković R
- Issue date: 2018 Oct 1
- Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach.
- Authors: Pavlopoulou A, Bagos PG, Koutsandrea V, Georgakilas AG
- Issue date: 2017 Sep 10
- Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.
- Authors: Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CM, Burnet NG
- Issue date: 2015 Oct
- Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.
- Authors: Cui Y, Li B, Pollom EL, Horst KC, Li R
- Issue date: 2018 Oct 1
- [Identification of predictive biomarkers to radiotherapy outcome through proteomics approaches].
- Authors: Lacombe J, Mange A, Azria D, Solassol J
- Issue date: 2013 Feb